+ All Categories
Home > Documents > Cardiology FM

Cardiology FM

Date post: 06-Jul-2018
Category:
Upload: trusha
View: 217 times
Download: 0 times
Share this document with a friend

of 25

Transcript
  • 8/17/2019 Cardiology FM

    1/25

    Cardiology – Internal MedicineCongestive Heart Failure

    • Overview

    o Final and most severe manifestation of nearly every form of cardiac disease

    o Inability of the heart to pump blood forward at a sucient rate to meet the metabolic demands of the body (forward

    failure) or the ability to do so only if the cardiac lling pressures are abnormally high (bacward failure)o !reventive therapy " patient education is the ey to reduction of burden

    !athophysiology of Heart Failureo Heart failure most commonly results from conditions of impaired left ventricular function (myocardial failure)

    # systolic dysfunction

    o $ummari%ed as an imbalance in $tarlings forces or an imbalance in the degree of end&diastolic ber stretch

    proportional to the systolic mechanical wor e'pended in the ensuing contraction (basically lie a rubber band themore it is stretched the greater the releasing velocity)

    o Chronic heart failure results from

    Impaired ventricular contractility

    • $ystolic dysfunction

    Increased afterload

    Impaired ventricular lling

    • iastolic dysfunctiono $ystolic ysfunction

    *+, of patients

    iminished capacity to e-ect blood

    • Impaired contractility

    • !ressure overload

    uring diastole persistently elevated ./ pressure transmitted to .0 (through the open mitral valve)  

    pulmonary veins 0n elevated pulmonary capillary hydrostatic pressure (1 *2 mmHg) results in the transudation of 3uid into the

    pulmonary interstitium $ymptoms of pulmonary congestion (.oss of contractility may result from damage to myocytes abnormal myocyte function or brosis)

    o iastolic ysfunction

    4+, of patients with clinical heart failure have normal ventricular contractile (systolic) function

    Filling of ventricle occurs at higher&than&normal pressures

    isplay abnormalities of ventricular diastolic function

    • Impaired early diastolic rela'ation

    • Increased sti5ness

    • Or both

    6levated diastolic pressure transmitted retrograde to pulmonary " systemic veins

    • Classication

    o Heart failure can also be classied as7

  • 8/17/2019 Cardiology FM

    2/25

    .eft&sided heart failure

    • 8ost common cause is left&sided heart failure

    • $ymptoms

    o yspnea on e'ertion

    o Orthopnea

    o !9 (paro'ysmal nocturnal dyspnea)

    o 9octurnal cough

    o Hemoptysis

    o Fatigueo ulled mental status

    o 9octuria

    • !hysical Findings

    o iaphoresis dusy

    o  :achycardia

    o  :achypnea

    o !ulmonary rales

    o Cardiac asthma

    o $, (; $ accepts blood volume at low pressures and e-ects against low

    pulmonary vascular resistance

    • Isolated rt&heart failure is less common and usually re3ects increased =/ afterload owing to disease ofthe lung itself or pulmonary vasculature

    • =ight&sided heart disease resulting from primary pulmonary process

    o Cor pulmonale (isolated =/ failure)

    • ?hen the right ventricle fails the elevated diastolic pressure is transmitted retrograde to the right

    atrium with subse@uent congestion of the systemic veins• Indirectly right&heart failure may also in3uence left&heart function

    o ecreased =/ output reduces blood returning to ./ (preload)

    o .eads to drop in ./ stroe volume

    • $ymptomso !eripheral edema

    o =AB discomfort

    o 0nore'ia

    o 9ausea

    o Ane'pected weight gain

    !hysical Findingso  /

    o Hepatomegaly

  • 8/17/2019 Cardiology FM

    3/25

    o !eripheral edema

    o !alpable parasternal =/ heave

    o $, or $<

    o 8urmur of :=

    o DDDDpleural e5usions may develop with either right sided or left sided failure

    • 6tiology

    o 8yocardial abnormalities

    C0 8I ischemia (chronic and silent) cardiomyopathy

    o Hemodynamic overload !ressure > 0$ H:9 massive !6 CO!

    /olume > valvular regurgitation anemia thyroto'icosis

    o /entricular lling abnormalities

    8itral stenosis constrictive pericarditis ./H

    o Cardiomyopathy

    ilated

    Hypertrophic

    o 0rrhythmia

    0F $/: mared bradyarrhythmias

    • Causes of HF in ?estern ?orldo For a substantial proportion of patients causes are7

    Coronary artery disease

    Hypertension

    ilated cardiomyopathy

    • 0ggravating Factorso Often a lac of response to conventional therapy for heart failure is due to the presence of uncorrected aggravating

    or precipitating factorsE It is important to always consider the possibility of such factors particularly in cases ofrefractory failure

    o 8ainly7

    8edications 9ew heart disease

    8yocardial ischemia

    o Other

    !regnancy

    0rrhythmias

    Infections

     :hromboembolism

    Hyper+hypothyroidism

    6ndocarditis

    Obesity

    H:9

    9oncompliance

  • 8/17/2019 Cardiology FM

    4/25

    ietary e'cess

    • $tages of Heart Failureo esigned to emphasi%e preventability of HF

    o esigned to recogni%e the progressive nature of ./ dysfunction

    o 0t =is for Heart Failure7

    $:06 0 High ris for developing HF

    $:06 G 0symptomatic ./ dysfunction

    o Heart Failure7

    $:06 C !ast or current symptoms of HF $:06 6nd&stage HF

    o CO8!.6869: O 9O: =6!.0C6 9H0 C.0$$6$

    9H0 Classes & shift bac+forth in individual patient (in response to =' and+or progression of disease)

    $tages & progress in one direction due to cardiac remodeling

    • iagnostic 0ids

    o C=

    Cardiac silhouette

    • Heart shadow should occupy J2K or less of the ma'imal width of thora'

    • $ome cases inaccurately re3ect heart si%e

    o 6levated diaphragmo 9arrow chest 0! diameter

    o !ericardial e5usion

    •  :herefore chest 0! diameter should be assessed on lateral view before frontal view to truly represent an

    enlarged heart !ulmonary 8anifestations of Heart disease

    • 0ppearance of pulmonary vasculature re3ects abnormalities of pulmonary arterial and venous pressures

    and pulmonary blood 3owEo Increased vascular marings

    o =edistribution of blood 3ow from bases to apices (cephali%ation)

    o

    !ulmonary edema (butter3y or bat&wing pattern)o 0bnormal septal lines (Lerley G lines)

    o !leural e5usions

    o 6chocardiography

    $afe noninvasive relatively ine'pensive

    High&fre@uency (ultrasonic) waves

     :hree types of modalities

    • 8&mode

    o First application of ultrasonography

    o !rovides limited data from one narrow ultrasonic beam

    o /aluable for7

    8easurement of wall thicness

    Chamber diameters

  • 8/17/2019 Cardiology FM

    5/25

    0ccurate timing of valve movements

    •  :wo&dimensional (*)o 8ultiple ultrasonic beams transmitted through a wide arc

    o =eturning signals produce *& images on screen

    o !arasternal and apical views

    $ome patients with CO! dicult to view > subcostal view

    • oppler imagingo 6valuates blood 3ow direction velocity and turbulence

    o !ermits estimation of pressure gradientso Colors are superimposed on *& images showing location of stenotic and regurgitant valvular

    lesionso Can also show abnormal communications w+in heart and great vessels

    • iagnostic ?orup

    o In all cases7

    History !hysical 6'am 6L

    6cho

    • 6tiology

    • 8=M (diastolic dysfunction) =/ f'n

    • Can measure pressures Chest '&ray

    .abs

    •  :$H 9a L Cr G9!

    0ssessment for C0

    • One of few reversible causes

    o In selected cases

    .abs

    • 8etanephrines

    • Ferritin

    Catheteri%ation

    • C0

    • Hemodynamics

    6ndomyocardial biopsy

    • If inltrative disease considered

    o =ight&heart catheteri%ation

    =ight heart

    • 0ccess from peripheral vein

    • 8easure pressures in =0 =/ " !0

    • uided by 3uoroscopy

    • Ase speciali%ed balloon&tipped catheter• =ecorded pressures identify the catheter tipNs position

  • 8/17/2019 Cardiology FM

    6/25

    !ulmonary artery wedge pressure

    • !0?! or !C?o Closely matches .0 pressure in most people

    • ?hen 8/ open during diastole

    o !ulmonary venous bed .0 ./ normally share same pressure

    • DD:hus !0?! can be used to estimate ./ end&diastolic pressure > a measurement of preloadDD

    •  :reatment

    o Overview

    Identify and correct underlying conditions 6liminate acute precipitating factors

    8odulation of neurohormonal response

    8anagement of symptoms

     :reat congestion

    Increase forward cardiac output

    Improvement of long&term survival

    o $tage 0

     :reat nown ris factors > H:9 8 etc

    .ifestyle modications > avoid smoing e'cessive use of alcohol illicit drug use

    !eriodic eval > 6cho

    Control ventricular rate restore sinus rhythm

    0C6&I 0=G$

    o $tage G

     :reat nown ris factors > H:9 8 etc

    .ifestyle modications > avoid smoing e'cessive use of alcohol illicit drug use

    rug therapy for all patients

    • 0C6I or 0=Gs

    • Geta&Glocers

    ICs in appropriate patients (implantable cardioverter debrillator)

    Coronary revasculari%ation in appropriate patients /alve replacement or repair in appropriate patients

     :herapies 9O: recommended

    • igo'in should not be used in patients with low 6F sinus rhythm and no history of HF symptoms

    because in this population the ris of harm is not balanced by any nown benetE

    • Calcium channel blocers with negative inotropic e5ects may be harmful in asymptomatic patients withlow ./6F and no symptoms of HF after 8I

    o $tage C

    rug therapy for all patients

    • iuretics for 3uid retention

    0C6I or 0=Gs• Geta&blocers

    rug therapy for selected patients

  • 8/17/2019 Cardiology FM

    7/25

    • 0ldosterone 0ntagonists

    • igitalis

    • Hydrala%ine+nitrates

    ICs in appropriate patients

    Cardiac resynchroni%ation in appropriate patients

    o $tage

    =ecommended :herapies Include7

    • Control of 3uid retention

    • =eferral to a HF program for appropriate patients• iscussion of options for end&of&life care

    o Informing re7 option to inactivate debrillator

    • evice use in appropriate patients

    • $urgical therapy >

    o Cardiac transplantation

    o 8itral valve repair or replacement

    • rug :herapy >o !ositive inotrope infusion as palliation in appropriate patients

    $everal therapies should be avoided when possible in patients with systolic HF

    •  :hia%oladinediones (glita%ones) > medication for 8 that can worsen HF• Calcium channel blocers

    o 6'cept amlodipine and felodipine

    • 9$0I$ and CO * inhibitors

    o Cause 9a and H*O retention

    • Combination of 0C6&inhibitor 0=G and aldosterone blocer

    o Increased ris of hyperalemia

    0ggravating factors

    • Often a lac of response to conventional therapy for heart failure is due to the presence of uncorrected

    aggravating or precipitating factorsE It is important to always consider the possibility of such factors

    particularly in cases of refractory failureo Other 0dd&ons if needed

    0ldosterone 0ntagonist :herapy

    • Chronic e'cess of aldosterone contributes to cardiac brosis and adverse ventricular remodeling

    • $pironolactoneo substantially reduces mortality rates reduces hospitali%ations and improves symptoms when

    added to 0C6 inh " diuretics Chronic therapy using combination of

    • /enous dilator > isosorbide dinitrate plus

    • 0rteriolar dilator > hydrala%ine

    • $hown to improve therapy of moderate symptoms of HF• Ase when intolerance to 0C6 inh or 0=G therapy

  • 8/17/2019 Cardiology FM

    8/25

    • !articular benet in 00 with HF

    Inotropic drugs (digitalis)

    9O: useful in diastolic dysfunction  systolic only

    Genets7

    • 6nhance contractility

    • =educes cardiac enlargement

    • Improves symptoms

    • 0ugments cardiac output (with sysE HF)

    • 0dded benet in patients with 0Fib• Has not been shown to improve long-term survival

    o 0dditional :herapy

    0nticoagulation

    • If 0F or ./ thrombus

     :reatment of atrial or ventricular arrhythmias

    Insertion of an implantable cardioverter&debrillator (IC)

    • ./6F ,JK

    • 0t least 4 month post 8I or

    • , months post revasculari%ation

    • 9H0 class II or III HF

    • 0bove regardless of previous documented ventricular arrhythmiaPP

    Giventricular pacemaer

    • Interventricular conduction abnormalities and widened B=$ comple'es are common in patients with

    advanced HFo Ancoordinated patterns of right and left ventricular contractions

    •  :herapy7o 0ugments ./ systolic function with an accompanying reduction of ./ si%e

    o Improves e'ercise capacity

    o =educes fre@uency of HF e'acerbations

    o =educes mortality• Indications

    o ./6F ,JK

    o B=$ Q 4*2 msec and

    o 9H0 Class III or I/ HF

    • iastolic ysfunction

    o 0rea of ongoing research > no clear cut pharmacologic recommendations

    o Inotropic drugs or vasodilators usually have no role in the treatment of pure diastolic dysfunction

    o =is of death lower than systolic dysfunction

    o '7 doppler echocardiography

    o  :reat symptomatically and prevent reversible causeso Causes7

  • 8/17/2019 Cardiology FM

    9/25

    H:9

    Hypertrophic cardiomyopathy

    8yocardial infarction

    =estrictive cardiomyopathy

    0ortic stenosis with normal 6F

    Coronary artery disease

    !ericarditis

    • 0cute !ericarditis

    o 8ost common aRiction of pericardiumo In3ammation of layers

    o 6tiology

    Infectious

    • /iral + Idiopathic > most often

    • !neumococcus and staphylococci most fre@uently responsibleS gram&negative infection occurs less ofteno 8echanisms of entry for Gacterial !ericarditis

    !erforating trauma to chest

    Contamination during chest surgery

    6'tension of intracardiac infection

    6'tension of pneumonia Hematogenous spread from remote infection

    •  :uberculosiso .ow incidence in AE$E

    o  :G remains problem worldwide

    o Important cause in immunosuppressed patients especially 0Is

    • !yogenic bacteria & rare

    9oninfectious

    • !ost 8I

    o 6arly > rst few days

    In3ammation e'tending from epicardial surface

    8ost common with transmural 8I

    !rognosis following acute 8I not a5ected

    T JK of patients

    o .ater > resslerNs syndrome

    * wees to several months post 8I

    M autoimmune

    • Aremia

    • 9eoplastic disease

    • =adiation&induced

    • Connective tissue disorder• rug&induced

  • 8/17/2019 Cardiology FM

    10/25

    o !athogenesis

    .ocal vasodilation with transudation of protein&poor cell&free 3uid into pericardial space

    Increased vascular permeability with lea of protein into pericardial space

    .euocyte e'udation

    • Help contain or eliminate o5ending agent

    8etabolic products released by these cells may

    • !rolong in3ammation

    • Cause pain and local cellular damage

    • 8ediate somatic symptoms iEeE fever  :he immune response to pericardial in-ury may signicantly contribute to tissue damage and symptomatology

    o !athology

     :he pathologic appearance of the pericardium depends on the underlying cause and severity of in3ammation

    $erous pericarditis

    • Characteri%ed by scant polymorphonuclear leuocytes lymphocytes and histiocytes

    • 6'udate is thin 3uid secreted by mesothelial cells lining the serosal surface of the pericardium

    • .iely represents early in3ammatory response common to all types of acute pericarditis

    $erobrinous pericarditis

    • 8ost common

    • Contains plasma proteinso rossly rough and shaggy appearance

    • !ortions of visceral and parietal pericardium may become thicened and fusedo Occasionally this process leads to dense scar

    o =estricts movement and diastolic lling

    $uppurative (purulent) pericarditis

    • Intense in3ammatory response associated with bacterial infection

    • $erosal surfaces are erythematous and coated with purulent e'udate

    Hemorrhagic pericarditis

    • rossly bloody form

    • 8ost often caused by :G or malignancyo Clinical Features

    8ost fre@uent symptoms of acute pericarditis are C! " fever

    Chest pain > sharp pleuritic

    • C! located retrosternal area and left precordiumS may also radiate to the bac and ridge of the left

    trape%ius muscle

    • 0ggravated by coughing and inspiration

    Fever

    !ositional > sitting + leaning forward eases pain

    yspnea (none'ertional)

    • yspnea common but not e'ertional > most liely from a reluctance of pt to breathe deeply b+c ofpleuritic pain

  • 8/17/2019 Cardiology FM

    11/25

    o !hysical Findings

     :achycardia

    Friction rub

    • Gest heard leaning forward while e'haling

    • $@ueay high&intensity sound heard best at left lower parasternal edge

    • iaphragm

    • , componentso /entricular contraction

    o /entricular rela'ationo 0trial contraction

    o iagnostic $tudies

    6L > abnormal U2K of cases

    • i5use $: segment elevation

    • != segment depression

    o != segment depression re3ects abnormal atrial repolari%ation related to atrial epicardial

    in3ammation

    .ab

    • 6levated ?GC count

    • 6levated 6$=

    6chocardiography

    • 0ssess for pericardial e5usion

    o  :reatment

    Asually self&limited (4&, wees)

    • /iral+idiopathic usually self&limiting

    =est !ain relief 

    • 0nalgesic

  • 8/17/2019 Cardiology FM

    12/25

    • 0nti&in3ammatory

    o 0$0+9$0Is

    o Corticosteroids > severe or recurrent

    Corticosteroids should not be given for uncomplicated casesE !otentially severe side

    e5ects and b+c even gradual withdrawal of this form of therapy often leads to recurrentsymptoms of pericarditis

    o !urulent pericarditis

    8ore aggressive treatment

    Catheter drainage of pericardium Intensive antibiotic therapy

    8ortality rate very high

    • Constrictive !ericarditis

    o 0s blood passes from the =0 into the =/ during diastole the =/ si%e e'pands and @uicly reaches the limit imposed

    by the constricting pericardiumE 0t that point further lling is suddenly arrested and venous return to the rightheart ceasesE :hus systemic venous pressure rises and signs of right&sided heart failure ensueE In addition theimpaired lling of the ./ causes a reduction in stroe volume and CO which leads to hypotension

    o =esults from pericardium becoming brosed and thicened

    /iral infectious post&surgical autoimmune

    o =estricts the normal lling of the heart during diastole

    o =estriction results in low&output failure

    Initially right&sided

     :hen left&sided

    o 6'amination

    6levated /!

    LussmaulNs sign > increase in /! with inspiration

    • LussmaulNs sign is the opposite of what is found in normal physiology where inspiration results in a

    decline in /! $oft heart sounds

    0trial brillation common

    o Cardiac catheteri%ation is diagnostic 6levation and e@uali%ation of the diastolic pressures in each of the cardiac chambers

    9ormal left ventricular function on ventriculogram

    o  :reatment

    !ericardectomy

    If :G medical therapy for 4 year

    • !ericardial 65usion > can be a complication of !ericarditis  see critical care

    !eripheral /ascular isease

    • Overview

    o 9umber of diverse pathologic entities a5ecting arteries veins and lymphatics

    o !/ results from $tructural changes in vessel wall

  • 8/17/2019 Cardiology FM

    13/25

    • degenerative conditions infection or in3ammation > lead to dilation aneurysm disseciton or rupture

    9arrowing of vascular lumen

    • atherosclerosis thrombosis or in3ammation

    $pasm

    • 0ortic aneurysm

    o 0bnormal locali%ed dilatation of an artery

    iameter has increased by at least J2K compared with normal

    o Clinical !resentation

    8a-ority asymptomatic• Incidental nding on imaging

    $ymptoms related to compression of other structures

    •  :horacic > compress mainstem bronchus causing cough dyspnea pneumonia

    • 6sophagus compression > dysphagia hoarseness (recurrent laryngeal nerve)

    • 000 > bac pain or nonspecic I symptomso !hysical 6'am

    !ulsatile mass

    8urmur aortic regurgitation

    Features of 8arfanNs syndrome

    o iagnosis Altrasound

    • 8ost useful and least e'pensive mode of diagnosis

    • Gest used to assess progression of 000 si%e

    • 0verage e'pansion of 2E< cm+year 000 and 2E4 cm+year thoracic

    Contrast&enhanced C:

    8=0 > 8=I with contrast

    o Complication

    =upture in any location produces acute symptoms

    • $evere pain

    • .OC• $hoc

    • eath (result of massive internal hemorrhage)o 4J222 lives per year taen due to rupture

    4,th leading cause of death

    o V cm 000s will rupture in J years

    o 0verage survival if untreated is 4W months

    9atural history > =is of rupture related to si%e of aneurysm

    o  :reatment

    Gased on si%e and patientNs overall medical conditions

    Close monitoring every V > 4* months if asymptomatic

    6lective surgical intervention if symptomatic (regardless of si%e)

  • 8/17/2019 Cardiology FM

    14/25

    o 0scending vs escending vs 0bdominal

    6tiology

    8ultifactorial depends on location

    • 0scending thoracic aortic aneurysms7

    o 0ging H:9 connective tissue disorders (8arfanNs)

    o 8ore common in men

    o Fusiform

    o Often e'tend into aortic arch

    o 6tiology7 8arfanNs

    • Inherited disorder autosomal dominant

    • 0ortic root tends to enlarge in fusiform fashion in association with aortic valvular

    regurgitation

    • Characteri%ed primarily by7

    o olichostenomelia (long thin e'tremities)

    o .igamentous redundancy

    o 6ctopia lentis

    o 0scending aortic dilatation

    o Incompetence of aortic "+or mitral valves Gicuspid aortic valve

    • !atients born with bicuspid aortic valve have structural abnormalities of the

    ascending aortao !redisposes to aneurysm and dissection

    • 0neurysm may develop before clinical symptoms of aortic stenosis

    • 05ects *K of population (* in *22)

    o Clinical !resentation

    !ain anteriorly under the breast bone

    • escending thoracic aneurysms7

    o 0therosclerosis " associated ris factors 8a-ority are atherosclerotic in origin

    • 8ay develop in patients with aortic coarctation

    o  :ypically fusiform

    o 8ay e'tend to level of abdominal aorta

    o Often begin distal to left subclavian artery

    o Clinical presentation

    Interscapular region + upper bac discomfort

    • abdominal aortic aneurysms

    o 0therosclerosis " associated ris factors

    o

    1U2K cases distal to renal arteries  :ermed > infrarenal abdominal aortic aneurysm

    o 0therosclerosis

  • 8/17/2019 Cardiology FM

    15/25

  • 8/17/2019 Cardiology FM

    16/25

    • 0cute dissections

    o  symptoms of less than * wees duration

    $udden severe pain

    YtearingZ YrippingZ

    • 0nterior substernal chest pain > type 0

    • $capular+bac pain > type G

    Can radiate anywhere

    • Consider aortic dissection and ruptured thoracic or abdominal aneurysm in the di5erential diagnosis of

    chest abdominal or bac painP !ainless occurs in about 4JK cases

    8ay present with clinical features of shoc if resultant cardiac tamponade or signicant blood loss

    o Imaging

    C: angiography

    • Can e5ectively e'clude the ma-or forms of life&threatening thoracic pathology

    &imer

    • Giomarer indicating activation of the coagulation system

    • ?hen negative e'cludes acute aortic dissectiono Complications

    !ericardial tamponade $troe

    8I

    =enal failure

    .imb ischemia

    0ortic regurgitation

    o  :reatment

    oal > arrest progression of dissection

    If suspicion of dissection

    • =educe $G!

    • ecrease force of ./ contractiono I/ 9: sodium nitroprusside GGs vasodilators

     :ype 0

    • 6arly surgical correction indicated

    • High ris for death intrapericardial rupture aortic reguritation or 8I

     :ype G

    • Initially aggressive medical therapy alone

    o GG [ afterload reducer

    • 6arly surgical intervention does not improve outcomeE $' indicated if7

    o continued propagation

    o compromise of ma-or branches of aortao impending rupture

  • 8/17/2019 Cardiology FM

    17/25

    o continued pain

    • !0

    o Overview

    Formation of atherosclerotic pla@ues in large and medium&si%ed arteries

    !athology + pathophysiology is identical to that of C0

    • toes lateral malleolus painful

    • 0rterial

    o

     :rauma heels + toeso !ainful

    o iscrete edges & Ypunched outZ

    o 6dges covered with crust

    o Infected erythematous

    o =apidly developing

    • /enous

    o .eads to stasis ulceration

    o !ainless

    o 0nle + lower leg above medial malleolus

    o =eddened thicened over medial malleolus

    o Cobblestone appearance

    o Occurs with slightest trauma

  • 8/17/2019 Cardiology FM

    18/25

    o $low developing

    o iagnostic $tudies

    0GI

    • 0nle&brachial inde'

    • 8easure systolic G! with oppler in

    o each arm and

    o dorsalis pedis and posterior tibial pulses

    • ivide the anle pressure by the arm pressure bilaterally

    • 4E2 > 4E, # 9ormal which means the anle pressure is e@ual to or slightly greater than that in the arms• T2EU

    o iagnostic of !0

    o Asually with symptoms of intermittent claudication

    • T2EJ

    o $evere !0 with critical leg ischemia

    o Often have pain at rest

    uple' ultrasonography

    8=0

    C:0

    Intra&arterial contrast angiographyo  :reatment

    0ntiplatelet therapyDD

    • 0$0 > shown to reduce C/ morbidity and mortality

    =is factor modicationDD

    • $moing cessation lipid management H:9 management 8 management

    $upportive care of feet + prevent trauma

    Formal e'ercise program > 4st line treatment

    8edical therapy

    • Cilosta%ol (!letal)

    o $elective phosphodiesterase inhibitoro /asodilator and platelet inhibitor properties

    o Improves e'ercise capacity

    • !ento'ifylline (:rental)

    o Improve deformability of =GC " ?GC

    o 8ay improve claudication symptoms

    • 0rea for lot of new and ongoing research

    =evasculari%ation

    • Indicated after failed medical therapy

    • Or in cases of severe limb ischemia

    oal > heal ulcers prevent limb loss• !:0 (percutaneous transluminal angioplasty)

  • 8/17/2019 Cardiology FM

    19/25

    • $urgery

    DD reduce ris of coronary events

    • 0cute 0ortic Occlusion

    o Caused by emboli%ation or thrombus

    Origin of arterial emboli usually cardiac

    8itral stenosis

    0trial brillation

    0cute 0?8I

    Infective endocarditis

    o =arely originate from venous circulation

    !arado'ical embolism

    • 0rterial embolism from venous circulation

    o Clot passes through an abnormal intracardiac communication (0$ /$ !FO)

    o $ymptoms

    0brupt total or near&total occlusion of terminal aorta or common iliac arteries poses immediate threat to life

    and limb 0brupt onset of severe pain

    • .umbar area buttocs perineum abdomen and legs

    i5use cyanosis• From umbilicus to feet

    • .ower limbs pale and cold

    9umbness paresthesia and paralysis

    0bsent pulses of lower limbs

    8uscle necrosis may produce myoglobinuria renal failure acidosis hyperalemia and death unless circulation

    restored promptlyo  :reatment

    0nticoagulation

    Immediate revasculari%ation procedure7 limb viability at ris

    High mortality rate•  :aayasu and iant Cell arteritis > vasculitic syndromes

    o  :ell di5erence between two

     :aayasu arteritis

    • Chronic vasculitis unnown etiology

    •  :argets aorta and ma-or brancheso 0ELE0E Ypulseless diseaseZ or Yaortic arch syndromeZ

    • X2 > U2K women onset age 42 >

  • 8/17/2019 Cardiology FM

    20/25

    o Once arterial obstruction develops A6 claudication from subclavian artery stenosis

    0bsent or diminished carotid or limb pulses (XJK)

    • Focal symptoms related to artery a5ected

    • Hypertension observed in \ of the cases

    o $ometimes malignant > suggesting narrowing of the aorta pro'imal to renal arteries

    • Cardiac manifestations result from severe H:9 dilatation of aortic root or coronary artery stenosis

    • iagnosis > V ma-or criteria

    o Onset by age demonstrates hypoechoic halo around involved vesselo iagnosis conrmed by biopsy of temporal artery

    o  :reatment

     :aayasu 0rteritis

    • $teroid and cytoto'ic drugs reduce in3ammation

    • $urgical bypass

    iant Cell arteritis

    o o not wait on result of biopsy to start treatmentPP

    o High&dose steroids

    o V2 mg daily

    o $elf&limited course 4 > J years

    • =aynaud !henomenono /asospastic disease of digital arteries

  • 8/17/2019 Cardiology FM

    21/25

    iagnosed by history

    Classically dened as episodes of discoloration of white ischemia then blue stasis then red hyperemia

    (recovery phase)o 6'treme vasoconstriction that temporarily obliterates vessel lumen

    Cold e'posure or emotional stress triggers spasms

    o  :riphasic color response

    ?hite > nger and+or toes interruption of blood 3ow

    Cyanosis > local accumulation of desaturated hemoglobin

    =uddy color > blood 3ow resumeso =aynaud disease

    Isolated primary disorder

    !redominantly women

    • ages *2 >

  • 8/17/2019 Cardiology FM

    22/25

    • Continue this process until the white area turns pin or a normal healthy colorE

    If triggered by e'posure in a cold environment and no warm water is available

    • place the a5ected digits in a warm body cavity & arm pit crotch or even in the mouthE

    • Leep the a5ected area warm at least until the whiteness returns to pin or a healthy color avoid

    continued e'posure to the coldEo rug :herapy

    !revent vasospasm

    • Calcium channel blocers

    • ]&adrenergic blocers• /aricose /eins

    o /eins7 High capacitance vessels

    Contain 1W2K of total blood volume

    eep or supercial

    o Overview

    ilated tortuous supercial vessels

    Common in lower e'tremities especially saphenous veins

    • 0norectal area

    • .ower esophageal veins

    • $permatic cord (varicocele) ?omen * & ,' more than men

    \ patients have family history

    =esults from

    • Intrinsic weaness of vessel wall

    • Increased intraluminal pressure

    • Congenital defects of valves

    o !rimary vs $econdary

    !rimary

    • Familial

    • $upercial system• !regnancy prolonged standing obesity

    $econdary

    • 0bnormality of deep venous system causes supercial varicosities

    o Incompetent perforating veins

    o eep venous insuciency or occlusion (/:)

    o 0rteriovenous stulas

    • In such cases deep venous blood shunted retrograde through perforating channel into supercial veins

    o Increases intraluminal pressure and volume

    o $ymptoms

    8any asymptomatic Gurning bursting bruised or aching

  • 8/17/2019 Cardiology FM

    23/25

    6'acerbated by prolonged standing or volume overload states

    6levation relieves symptoms

    o  :reatment

    $ought for cosmetic reasons

    6levate legs while supine

    0void prolong standing

    ?ear e'ternal compression stocings

    In-ection of sclerosing agent

    .aser > small veins =adiofre@uency ablation and surgical vein ligation

    • $upercial :hrombophlebitis and /:o /enous thrombosis

     :hrombus formation within supercial or deep vein

    Initially thrombus composed of platelets and brin

    .ater =GCs become interspersed within brin

     :hrombus tends to propagate in direction of blood 3ow

     :wo inds > supercial thrombophlebitis and /:

    o Lnow di5erence between two

    $upercial :hrombophlebitis

    • Genign disorder

    • In3ammation and thrombosis of supercial vein

    o  :ender erythematos indurated lesion in the course of a supercial vein

    o 8ay occur as a complication of an in&dwelling I/ catheter

    • Clinical !resentation

    o 6rythema

    o 6dema

    o  :enderness

    o Cellulitis is common

    •  :reatmento $elf&limited

    o .ocal heat

    o =est

    o 0$0 or anti&in3ammatory

    o 0b' if cellulitis present

    o 9o need to anticoagulate

    eep /enous :hrombosis

    • 8ost commonly veins of calves

    • 8ay also develop more pro'imally

    o !opliteal femoral iliac

    • $igns and $ymptomso 9onspecic

  • 8/17/2019 Cardiology FM

    24/25

    o Anreliable

    o Ob-ective testing should be obtained whenever the diagnosis is entertained

    • High inde' of suspicion

    • * ma-or conse@uenceso !ulmonary embolism

    /: from pro'imal veins of .6

    !leuritic C!

     :achypnea

    Cough dyspnea V22222 + year often fatal

    Antreated mortality rate   ,2 >

  • 8/17/2019 Cardiology FM

    25/25

    • !hysical 6'amination

    o 6dema of involved leg

    o .ocali%ed warmth and erythema

    o  :enderness over course of vein

    !alpable deep venous cord

    o Homans sign

    Calf pain produced by dorsi3e'ion of foot

    9onspecic and unreliable sign

    iagnosiso &imer

    Gyproduct brin degradation

    Highly sensitive for /:+!6 but not specic

    o /enous compression duple' ultrasonography

    UJK sensitive in pro'imal vein

    WJK sensitive in calf vein

    •  :reatmento 6levation reduces edema

    o 0nticoagulation > prevents e'tension of thrombus and !6

    .8?H

    ?arfarin

    • target I9= *E2 > ,E2

    • V & 4* months

    I/C lter

    • !rophyla'iso Gedrest following surgery

    o !rolonged bedrest

    o ive .8?H

    • iagnosis and management

    o For general surgical patients at low ris (minor operations less than


Recommended